{"date":"2026-05-28","count":31,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-1752-2026-05-28-1932-1yq643z","company_id":"1752","company":"南光","market":"上市","industry":"生技醫療","date":"2026-05-28","time":"19:32:52","subject":"公告本公司115年股東常會通過解除董事競業禁止之限制案","clause":"第21款","fact_date":"2026-05-28","cite_as":"公開資訊觀測站重大訊息：南光（1752），2026-05-28 19:32，「公告本公司115年股東常會通過解除董事競業禁止之限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1752-2026-05-28-1932-1m9yg14","company_id":"1752","company":"南光","market":"上市","industry":"生技醫療","date":"2026-05-28","time":"19:32:03","subject":"公告本公司審計委員會成員異動","clause":"第6款","fact_date":"2026-05-28","cite_as":"公開資訊觀測站重大訊息：南光（1752），2026-05-28 19:32，「公告本公司審計委員會成員異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1752-2026-05-28-1930-s0kpz3","company_id":"1752","company":"南光","market":"上市","industry":"生技醫療","date":"2026-05-28","time":"19:30:38","subject":"公告本公司董事會推選董事長","clause":"第6款","fact_date":"2026-05-28","cite_as":"公開資訊觀測站重大訊息：南光（1752），2026-05-28 19:30，「公告本公司董事會推選董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1752-2026-05-28-1929-6c9poe","company_id":"1752","company":"南光","market":"上市","industry":"生技醫療","date":"2026-05-28","time":"19:29:30","subject":"本公司115年股東常會全面改選董事(含獨立董事)當選名單","clause":"第6款","fact_date":"2026-05-28","cite_as":"公開資訊觀測站重大訊息：南光（1752），2026-05-28 19:29，「本公司115年股東常會全面改選董事(含獨立董事)當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1752-2026-05-28-1928-ssvo5d","company_id":"1752","company":"南光","market":"上市","industry":"生技醫療","date":"2026-05-28","time":"19:28:11","subject":"115年股東常會重要決議事項","clause":"第18款","fact_date":"2026-05-28","cite_as":"公開資訊觀測站重大訊息：南光（1752），2026-05-28 19:28，「115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2026-05-28-1828-6j2n9d","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2026-05-28","time":"18:28:04","subject":"本公司註銷買回庫藏股辦理完成","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2026-05-28 18:28，「本公司註銷買回庫藏股辦理完成」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2026-05-28-1827-b1ixfc","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2026-05-28","time":"18:27:42","subject":"代子公司康君諮詢管理(上海)公告累計處分理財產品達公告標準","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2026-05-28 18:27，「代子公司康君諮詢管理(上海)公告累計處分理財產品達公告標準」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2026-05-28-1825-qjl5ua","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2026-05-28","time":"18:25:02","subject":"本公司新藥CBL-514注射劑用於減少腹部皮下脂肪之第二個多國多中心樞紐三期臨床試驗CBL-0302申請，今日加拿大HC已核准執行","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2026-05-28 18:25，「本公司新藥CBL-514注射劑用於減少腹部皮下脂肪之第二個多國多中心樞紐三期臨床試驗CBL-0302申請，今日加拿大HC」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3218-2026-05-28-1752-v8gwjg","company_id":"3218","company":"大學光","market":"上櫃","industry":"生技醫療","date":"2026-05-28","time":"17:52:32","subject":"公告本公司預計於新台幣3億元額度內取得有價證券","clause":"第20款","fact_date":"2026-05-28","cite_as":"公開資訊觀測站重大訊息：大學光（3218），2026-05-28 17:52，「公告本公司預計於新台幣3億元額度內取得有價證券」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4114-2026-05-28-1746-1jb8ii5","company_id":"4114","company":"健喬","market":"上櫃","industry":"生技醫療","date":"2026-05-28","time":"17:46:42","subject":"公告本公司115年股東常會重要決議事項","clause":"第18款","fact_date":"2026-05-28","cite_as":"公開資訊觀測站重大訊息：健喬（4114），2026-05-28 17:46，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1788-2026-05-28-1739-1ewxucf","company_id":"1788","company":"杏昌","market":"上櫃","industry":"生技醫療","date":"2026-05-28","time":"17:39:38","subject":"公告本公司114年現金股利配息基準日","clause":"第14款","fact_date":"2026-05-28","cite_as":"公開資訊觀測站重大訊息：杏昌（1788），2026-05-28 17:39，「公告本公司114年現金股利配息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1788-2026-05-28-1652-v6khu3","company_id":"1788","company":"杏昌","market":"上櫃","industry":"生技醫療","date":"2026-05-28","time":"16:52:20","subject":"公告115年股東常會重要決議事項","clause":"第18款","fact_date":"2026-05-28","cite_as":"公開資訊觀測站重大訊息：杏昌（1788），2026-05-28 16:52，「公告115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6808-2026-05-28-1651-15v000n","company_id":"6808","company":"三鼎生技","market":"興櫃","industry":"生技醫療","date":"2026-05-28","time":"16:51:41","subject":"公告本公司「METHOD FOR MANUFACTURING EXTRACELLULAR MATRIXCOMPOSITION」取得美國發明專利","clause":"第44款","fact_date":"2026-05-28","cite_as":"公開資訊觀測站重大訊息：三鼎生技（6808），2026-05-28 16:51，「公告本公司「METHOD FOR MANUFACTURING EXTRACELLULAR MATRIXCOMPOSITI」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4157-2026-05-28-1649-3il1nf","company_id":"4157","company":"太景*-KY","market":"上櫃","industry":"生技醫療","date":"2026-05-28","time":"16:49:02","subject":"公告本公司115年度股東常會重要決議事項","clause":"第18款","fact_date":"2026-05-28","cite_as":"公開資訊觀測站重大訊息：太景*-KY（4157），2026-05-28 16:49，「公告本公司115年度股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7427-2026-05-28-1639-1ak3m4o","company_id":"7427","company":"華上生醫","market":"興櫃","industry":"生技醫療","date":"2026-05-28","time":"16:39:02","subject":"公告華上生醫自主開發新一代表觀免疫調控抗癌候選新藥GNTbm-38，取得菲律賓發明專利","clause":"第44款","fact_date":"2026-05-28","cite_as":"公開資訊觀測站重大訊息：華上生醫（7427），2026-05-28 16:39，「公告華上生醫自主開發新一代表觀免疫調控抗癌候選新藥GNTbm-38，取得菲律賓發明專利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7814-2026-05-28-1617-nyrhqc","company_id":"7814","company":"海昌生技","market":"上櫃","industry":"生技醫療","date":"2026-05-28","time":"16:17:42","subject":"公告本公司將於115年06月03日舉行上櫃前業績發表會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：海昌生技（7814），2026-05-28 16:17，「公告本公司將於115年06月03日舉行上櫃前業績發表會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4105-2026-05-28-1615-1dk0sd9","company_id":"4105","company":"東洋","market":"上櫃","industry":"生技醫療","date":"2026-05-28","time":"16:15:07","subject":"公告本公司115年股東常會通過解除董事競業禁止之限制","clause":"第21款","fact_date":"2026-05-28","cite_as":"公開資訊觀測站重大訊息：東洋（4105），2026-05-28 16:15，「公告本公司115年股東常會通過解除董事競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4105-2026-05-28-1614-1jb8ii5","company_id":"4105","company":"東洋","market":"上櫃","industry":"生技醫療","date":"2026-05-28","time":"16:14:34","subject":"公告本公司115年股東常會重要決議事項","clause":"第18款","fact_date":"2026-05-28","cite_as":"公開資訊觀測站重大訊息：東洋（4105），2026-05-28 16:14，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6535-2026-05-28-1533-nm2vob","company_id":"6535","company":"順藥","market":"上櫃","industry":"生技醫療","date":"2026-05-28","time":"15:33:22","subject":"公告本公司股東會決議解除董事競業禁止限制","clause":"第21款","fact_date":"2026-05-28","cite_as":"公開資訊觀測站重大訊息：順藥（6535），2026-05-28 15:33，「公告本公司股東會決議解除董事競業禁止限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6535-2026-05-28-1532-cobe39","company_id":"6535","company":"順藥","market":"上櫃","industry":"生技醫療","date":"2026-05-28","time":"15:32:37","subject":"公告本公司115年股東常會重要決議","clause":"第18款","fact_date":"2026-05-28","cite_as":"公開資訊觀測站重大訊息：順藥（6535），2026-05-28 15:32，「公告本公司115年股東常會重要決議」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6748-2026-05-28-1532-1i6vb1o","company_id":"6748","company":"亞果生醫","market":"興櫃","industry":"生技醫療","date":"2026-05-28","time":"15:32:28","subject":"公告本公司瑞晶珂 膠原蛋白植入劑獲得衛福部食藥署三類醫材核准上市","clause":"第44款","fact_date":"2026-05-28","cite_as":"公開資訊觀測站重大訊息：亞果生醫（6748），2026-05-28 15:32，「公告本公司瑞晶珂 膠原蛋白植入劑獲得衛福部食藥署三類醫材核准上市」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4137-2026-05-28-1517-zg4pxh","company_id":"4137","company":"麗豐-KY","market":"上市","industry":"生技醫療","date":"2026-05-28","time":"15:17:53","subject":"公告本公司董事會決議關係人捐贈事宜","clause":"第43款","fact_date":"2025-12-18","cite_as":"公開資訊觀測站重大訊息：麗豐-KY（4137），2026-05-28 15:17，「公告本公司董事會決議關係人捐贈事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7851-2026-05-28-1503-1jb8ii5","company_id":"7851","company":"慧康生技*-KY","market":"興櫃","industry":"生技醫療","date":"2026-05-28","time":"15:03:29","subject":"公告本公司115年股東常會重要決議事項","clause":"第15款","fact_date":"2026-05-28","cite_as":"公開資訊觀測站重大訊息：慧康生技*-KY（7851），2026-05-28 15:03，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6491-2026-05-28-1442-1ot2cvp","company_id":"6491","company":"晶碩","market":"上市","industry":"生技醫療","date":"2026-05-28","time":"14:42:57","subject":"本公司受邀參加花旗證券舉辦之投資論壇","clause":"第12款","fact_date":"2026-06-03","cite_as":"公開資訊觀測站重大訊息：晶碩（6491），2026-05-28 14:42，「本公司受邀參加花旗證券舉辦之投資論壇」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4102-2026-05-28-1412-11rn8wu","company_id":"4102","company":"永日","market":"上櫃","industry":"生技醫療","date":"2026-05-28","time":"14:12:34","subject":"公告本公司115年股東常會通過解除董事(含獨立董事)競業禁止之限制","clause":"第21款","fact_date":"2026-05-28","cite_as":"公開資訊觀測站重大訊息：永日（4102），2026-05-28 14:12，「公告本公司115年股東常會通過解除董事(含獨立董事)競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4102-2026-05-28-1411-jflio5","company_id":"4102","company":"永日","market":"上櫃","industry":"生技醫療","date":"2026-05-28","time":"14:11:17","subject":"公告本公司115年股東會重要決議事項","clause":"第18款","fact_date":"2026-05-28","cite_as":"公開資訊觀測站重大訊息：永日（4102），2026-05-28 14:11，「公告本公司115年股東會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1762-2026-05-28-1410-1jb8ii5","company_id":"1762","company":"中化生","market":"上市","industry":"生技醫療","date":"2026-05-28","time":"14:10:11","subject":"公告本公司115年股東常會重要決議事項","clause":"第18款","fact_date":"2026-05-28","cite_as":"公開資訊觀測站重大訊息：中化生（1762），2026-05-28 14:10，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1777-2026-05-28-1408-1jb8ii5","company_id":"1777","company":"生泰","market":"上櫃","industry":"生技醫療","date":"2026-05-28","time":"14:08:46","subject":"公告本公司115年股東常會重要決議事項","clause":"第18款","fact_date":"2026-05-28","cite_as":"公開資訊觀測站重大訊息：生泰（1777），2026-05-28 14:08，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7827-2026-05-28-1237-1bmup04","company_id":"7827","company":"漢康-KY創","market":"上市","industry":"生技醫療","date":"2026-05-28","time":"12:37:48","subject":"公告本公司股票即將終止興櫃交易並轉至臺灣證券交易所上市交易","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢康-KY創（7827），2026-05-28 12:37，「公告本公司股票即將終止興櫃交易並轉至臺灣證券交易所上市交易」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7803-2026-05-28-1123-1tjf9j","company_id":"7803","company":"雲象科技-創","market":"上市","industry":"生技醫療","date":"2026-05-28","time":"11:23:19","subject":"公告本公司創新板上市掛牌首五個營業日穩定價格操作結果","clause":"第51款","fact_date":"2026-05-28","cite_as":"公開資訊觀測站重大訊息：雲象科技-創（7803），2026-05-28 11:23，「公告本公司創新板上市掛牌首五個營業日穩定價格操作結果」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3218-2026-05-28-1032-1dfxd4q","company_id":"3218","company":"大學光","market":"上櫃","industry":"生技醫療","date":"2026-05-28","time":"10:32:06","subject":"公告本公司一一五年股東常會重要決議事項","clause":"第18款","fact_date":"2026-05-28","cite_as":"公開資訊觀測站重大訊息：大學光（3218），2026-05-28 10:32，「公告本公司一一五年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}